Today: October 20, 2018, 12:20 am
  
Business

Endovision’s Range of Single-Use Forceps, Laproscopic Instruments Minimize Risk

Endovision’s Range of Single-Use Forceps, Laproscopic Instruments Minimize Risk
PR-Inside.com: 2017-11-28 09:57:20
Endovision Australia, a leader in providing surgical instruments to the medical community, stocks an exceptional range of Single Use Cholangiogram Forceps and Laparoscopic Instruments. The disposable products are popular with private and public hospitals as they guarantee a brand new instrument that has an uncompromised tip every time.


The Cholangiogram Forceps styles available are Tontarra and Optcla. The company offers Tontarra MAS-007-10, the original and best Single Use Cholangiogram forceps on the Australian market. Designed in Australia and made with German research and development this is widely popular with surgeons. It has been produced by Endovision after extensive research and development with partners in Germany. It manufactures the jaw components to the German-made tubes in Hungary. The assembly and quality control is performed at Tontarra’s facility in Wurmlingen and the final product is shipped to Stuttgart for packaging and sterilising.

Cholangiogram forceps cannot be cleaned. Single use is the only way to eliminate cross infection risks and guarantee sterility for every patient every time. Optcla is the Chinese-made alternative that is cost effective. The 121-30213 – OPTCLA Cholangiogram Forceps 33cm has a “central ratchet” style. Optcla is part of the extensive Mindray Group and is selling their product around the world.

Endovision stocks premium single use laparoscopic surgical instruments from Optcla. Optcla’s New Release Single Use laparoscopic instruments integrate naturally with the surgeons’ hand providing exceptional control. Optcla is a leading Chinese company that specialises in the production of minimal invasive surgical instruments. They produce high quality products that meet the needs of laparascopic surgery. As production costs are integrated into the design the end result is a high quality single use product that can be accommodated by health institutions of all sizes.

The original Optcla Single Use high quality laparoscopic instruments are available in a range of jaw options. All instruments provide a high level of tactile feedback for increased control and have a standard monopolar connection. Optcla bipolar instruments offer controlled bipolar coagulation and dissection of tissue across the full length of the jaw during laparoscopic surgery. The reduced thermal spread reduces the risk of damage to surrounding tissue and greatly reduces the risk of patient burns.

Endovision designs and sells single use instruments that have proven excellent clinical results. As a leader in their field the company has been working to reduce public risks associated with the use of Cholangiogram Forceps. It also stocks specialised niche products like Sunoptics Surgical, LED Headlights, High Definition Video Headlights, Xenon Lamps, Specialised Instrumentation and Pos-T-Vac to operating theatres.

To reach Endovision call 03 9550 1819 or email info@endovision.com.au. For more information on surgical equipment and medical instruments supplied by Endovision visit: www.endovision.com.au

Press Information
Endovision
21 Aristoc Road

Glen Waverly, Victoria 3150

Australia



03 9550 1819
email
www.endovision.com.au

Published by
Cam Wilkes
006499503888
e-mail
www.pureseo.co.nz



# 448 Words
Related Articles
 
More From Business
Rovio Entertainment and the Chicago Bulls Partner [..]
  New collaboration introduces the "Angry Birds Eye View Cam," a cutting-edge camera angle at Chicago Bulls home games [..]
The Navigators Group, Inc. Announces Expiration of [..]
STAMFORD, Conn., Oct. 19, 2018 (GLOBE NEWSWIRE) -- The Navigators Group, Inc. (NASDAQ:NAVG) (“Navigators” or the “Company”) announced [..]
ArcelorMittal selected as H1 bidder for Essar [..]
Luxembourg, 19 October 2018 - ArcelorMittal confirms it has been informed by the Committee of Creditors (“CoC”) for Essar [..]
NANOBIOTIX: Positive phase II/III results for NBTXR3 [..]
NANOBIOTIX: POSITIVE PHASE II/III RESULTS FOR NBTXR3 IN SOFT TISSUE SARCOMA PRESENTED AT ESMO Dr. Sylvie Bonvalot, Head of [..]
Arion Bank will publish its 9M 2018 [..]
Arion Bank will publish its financial results for the first nine months of 2018 on Wednesday 31. October, after markets [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.